1. Home
  2. SGRP vs GBIO Comparison

SGRP vs GBIO Comparison

Compare SGRP & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGRP
  • GBIO
  • Stock Information
  • Founded
  • SGRP 1967
  • GBIO 2016
  • Country
  • SGRP United States
  • GBIO United States
  • Employees
  • SGRP N/A
  • GBIO N/A
  • Industry
  • SGRP Business Services
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SGRP Consumer Discretionary
  • GBIO Health Care
  • Exchange
  • SGRP Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • SGRP 27.8M
  • GBIO 23.2M
  • IPO Year
  • SGRP 1996
  • GBIO 2020
  • Fundamental
  • Price
  • SGRP $1.14
  • GBIO $0.45
  • Analyst Decision
  • SGRP
  • GBIO Strong Buy
  • Analyst Count
  • SGRP 0
  • GBIO 4
  • Target Price
  • SGRP N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • SGRP 46.0K
  • GBIO 571.4K
  • Earning Date
  • SGRP 05-14-2025
  • GBIO 05-12-2025
  • Dividend Yield
  • SGRP N/A
  • GBIO N/A
  • EPS Growth
  • SGRP N/A
  • GBIO N/A
  • EPS
  • SGRP 0.50
  • GBIO N/A
  • Revenue
  • SGRP $228,869,000.00
  • GBIO $19,892,000.00
  • Revenue This Year
  • SGRP N/A
  • GBIO N/A
  • Revenue Next Year
  • SGRP N/A
  • GBIO $10.90
  • P/E Ratio
  • SGRP $2.24
  • GBIO N/A
  • Revenue Growth
  • SGRP N/A
  • GBIO 236.92
  • 52 Week Low
  • SGRP $1.04
  • GBIO $0.32
  • 52 Week High
  • SGRP $3.12
  • GBIO $4.34
  • Technical
  • Relative Strength Index (RSI)
  • SGRP 37.04
  • GBIO 52.81
  • Support Level
  • SGRP $1.04
  • GBIO $0.34
  • Resistance Level
  • SGRP $1.16
  • GBIO $0.46
  • Average True Range (ATR)
  • SGRP 0.07
  • GBIO 0.05
  • MACD
  • SGRP 0.01
  • GBIO 0.02
  • Stochastic Oscillator
  • SGRP 38.46
  • GBIO 93.33

About SGRP SPAR Group Inc.

SPAR Group Inc is a supplier of merchandising and other marketing services. It also provides range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from Americas.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: